Robustness of Significant Dichotomous Outcomes in Randomized Controlled Trials in the Treatment of Patients with COVID-19: A Systematic Analysis

PURPOSE: Significant results of randomized controlled trials (RCTs) should be properly weighed. This study adopted fragility index (FI) to evaluate the robustness of significant dichotomous outcomes from RCTs on coronavirus disease 2019 (COVID-19) treatment. MATERIALS AND METHODS: ClinicalTrials.gov...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qi, Chen, Hong, Gao, Yonghua, Zhu, Changju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836340/
https://www.ncbi.nlm.nih.gov/pubmed/36687387
http://dx.doi.org/10.1007/s44231-022-00027-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836340/
https://www.ncbi.nlm.nih.gov/pubmed/36687387
http://dx.doi.org/10.1007/s44231-022-00027-y

Ejemplares similares